TY  - GEN
AU  - Singh,Anjali
AU  - Lun,Xueqing
AU  - Jayanthan,Aarthi
AU  - Obaid,Halah
AU  - Ruan,Yibing
AU  - Strother,Douglas
AU  - Chi,Susan N
AU  - Smith,Amy
AU  - Forsyth,Peter
AU  - Narendran,Aru
TI  - Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting EGFR- ErbB2 signaling with lapatinib
SN  - 1878-0261
PY  - 2013///1223
KW  - Animals
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Cell Line, Tumor
KW  - Cell Movement
KW  - drug effects
KW  - Cell Survival
KW  - Cells, Cultured
KW  - Central Nervous System Neoplasms
KW  - drug therapy
KW  - Child
KW  - ErbB Receptors
KW  - metabolism
KW  - Female
KW  - Humans
KW  - Infant
KW  - Lapatinib
KW  - Male
KW  - Mice
KW  - Molecular Targeted Therapy
KW  - Quinazolines
KW  - Receptor, ErbB-2
KW  - Rhabdoid Tumor
KW  - Signal Transduction
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.molonc.2013.01.001
ER  -